Browse the evidence

In diet-induced obesity, brain glucose-sensing neurons (specifically in the arcuate nucleus and ventromedial hypothalamus) become hyporesponsive to glucose, leading to defective sympathetic regulation and contributing to metabolic efficiency and obesity development.

Obesity is not just a simple math problem of calories in vs. calories out; your brain's ability to sense glucose and regulate energy expenditure may be biologically impaired. This 'glucose sensing defect' makes your body more efficient at storing fat and resistant to weight loss. Understanding this biological resistance is key to addressing obesity, as it suggests that standard caloric restriction alone may be insufficient without addressing the underlying neural dysregulation.

Insulin-dependent diabetes (IDDM) and repeated hypoglycemia impair brain glucose sensing, leading to defective counterregulatory responses and hypoglycemia unawareness.

If you have type 1 diabetes, frequent low blood sugar episodes can damage your brain's ability to sense glucose and trigger the body's natural defense mechanisms (counterregulation). This leads to 'hypoglycemia unawareness,' where you don't feel the warning signs of a low. To protect your brain's sensing ability, it is critical to avoid repeated hypoglycemic episodes, even if it means accepting slightly higher average glucose levels.

Brain glucose-sensing neurons (GR and GS neurons) regulate energy homeostasis by modulating sympathetic and parasympathetic nervous system activity in response to glucose levels.

Your brain uses glucose levels as a signal to adjust your body's energy expenditure via the nervous system. When glucose rises, specific neurons (GR) and fall, others (GS) change their firing rates to regulate sympathetic and parasympathetic output. This is a key part of how your body maintains energy balance.

High concentrations of alpha-lipoic acid can have pro-oxidant and pro-apoptotic effects on pancreatic beta cells, potentially worsening diabetes pathology.

Be cautious with high doses of ALA. While therapeutic doses for neuropathy are safe, extremely high concentrations may harm pancreatic beta cells. Stick to clinically relevant doses.

Diets with lower energy density (higher water/fiber content from fruits and vegetables) are associated with significantly higher daily monetary costs compared to energy-dense diets (high in fats, sugars, and refined grains), regardless of total energy intake levels.

If you are trying to eat healthier by increasing fruits and vegetables, expect your grocery bill to go up. This is because energy-dense foods (fats, sugars, refined grains) are subsidized and processed to be cheaper per calorie than fresh produce. To manage costs, focus on affordable energy-dilute foods like potatoes, legumes, and seasonal vegetables, rather than assuming all 'healthy' foods are budget-friendly.

Extreme human longevity (centenarian status) is characterized by a distinct metabolic phenotype involving decreased serum tryptophan, specific remodeling of glycerophospholipids and sphingolipids, and altered gut microbiota metabolite excretion (phenylacetylglutamine and p-cresol sulfate).

This paper identifies metabolic signatures of longevity but does not offer a direct intervention. However, it suggests that maintaining healthy lipid profiles, managing inflammation, and supporting gut health (via microbiota) are biologically linked to exceptional longevity. Focus on a balanced diet that supports these metabolic pathways rather than seeking a single 'longevity pill'.

Centenarians exhibit enhanced cytochrome P450 (CYP) enzyme activity and anti-oxidative responses, evidenced by increased 8,9-EpETrE and decreased lipid peroxidation markers (9-HODE, 9-oxoODE).

Focus on supporting your body's natural enzymatic detoxification systems through a balanced diet rich in diverse nutrients, rather than relying on high-dose antioxidant supplements. The paper suggests that the *process* of metabolism and detoxification (CYP activity) is crucial for longevity.

Longevity is associated with increased urinary excretion of phenylacetylglutamine (PAG) and p-cresol sulfate (PCS), which mirror changes in gut microbiota structure and composition.

Support your gut health with a diverse, fiber-rich diet that promotes a healthy microbiome. This study links specific gut-derived metabolites (PAG, PCS) to longevity, suggesting that a healthy gut ecosystem is a component of exceptional aging.

Different forms of cell death (apoptosis, necroptosis, pyroptosis) in adipose tissue have distinct inflammatory consequences; necroptosis is highly inflammatory and linked to metabolic dysfunction, while apoptosis may trigger anti-inflammatory macrophage responses.

Not all fat loss is created equal. The way fat cells die matters. Necroptosis (inflammatory cell death) worsens metabolic health, while apoptosis might sometimes trigger a less inflammatory response. Strategies that minimize inflammatory cell death may be metabolically superior.

Omega-3 polyunsaturated fatty acid (n3-PUFA) supplementation promotes amyloid-beta clearance and protects AQP4 polarization, thereby enhancing glymphatic function.

Consider incorporating Omega-3 fatty acids (via diet or supplementation) to support brain health. Research suggests they help maintain the polarization of AQP4 channels, which are critical for the glymphatic system's ability to clear waste products like amyloid-beta from the brain.

There is insufficient evidence to set specific, quantified (time-based) recommendations for total sedentary time.

Do not worry about hitting a specific number of sitting hours. Instead, focus on the general principle of limiting sedentary time and breaking up long periods of sitting with light movement. The exact threshold varies by individual and health outcome.

There is a tentative but consistent increase in occasional and chronic insomnia-related symptoms among working-aged employees in Finland over the last 10 years of the study period, despite stable sleep medication usage rates.

If you are working and feeling more tired or having sleep issues, you are not alone; this is a documented trend in your demographic. However, this does not mean you need medication, as usage rates are stable. Focus on managing work stress and lifestyle factors rather than assuming you need pharmaceutical intervention.

Enhancing autophagic activity, particularly through genetic upregulation of autophagy-related genes (e.g., Atg5) or chaperone-mediated autophagy receptors (LAMP2A), extends lifespan and mitigates age-related physiological decline in mammalian models.

While you cannot directly 'dose' autophagy like a supplement, the paper highlights that nutrient restriction (Caloric Restriction) and specific stressors (like exercise or low-dose stressors inducing hormesis) activate autophagy. The most actionable takeaway is that maintaining metabolic flexibility and avoiding chronic overnutrition supports the autophagic clearance mechanisms that decline with age.

Decline in mitophagy and autophagy with age leads to the accumulation of damaged mitochondria and ROS, contributing to sarcopenia, neurodegeneration, and cardiovascular decline.

Exercise is a known inducer of autophagy and mitophagy. Maintaining physical activity, especially aerobic and resistance training, may help counteract the age-related decline in these clearance pathways, protecting muscle and brain health.

Cumulative duration of metformin use after prostate cancer diagnosis is associated with a significant, dose-dependent reduction in prostate cancer-specific mortality among diabetic men.

If you have diabetes and prostate cancer, continuing or starting metformin appears to significantly reduce your risk of dying from prostate cancer. The benefit increases with longer use. Discuss with your doctor whether maintaining metformin therapy is appropriate for your specific cancer treatment plan.

Citrus flavonoids (specifically nobiletin, diosmin, and 8-prenylnaringenin) demonstrate antidiabetic potential in vitro and in vivo by modulating glucose uptake, insulin sensitivity, and lipid metabolism through pathways such as PI3K/Akt, AMPK, and MAPK/ERK.

This paper reviews preclinical evidence that citrus flavonoids (like nobiletin and diosmin) may help manage blood sugar and lipids. However, it explicitly notes these effects have not yet been verified in human studies. Do not use these supplements to replace prescribed diabetes medication without consulting a physician.

Curcumin inhibits NF-κB signaling and reduces cancer proliferation in multiple cancer types, including breast, pancreatic, skin, liver, and colon cancer, in mouse models.

Curcumin, found in turmeric, shows promise in reducing cancer risk in animal studies by inhibiting inflammatory pathways. However, its low bioavailability limits its current use as a standalone treatment, and research is focused on improving its absorption.

Conjugated linoleic acid (CLA) supplementation, particularly the trans-10, cis-12 isomer, reduces body fat and adiposity in animal models through mechanisms involving PPAR modulation and SCD-1 inhibition, but in humans, it often fails to significantly affect body composition or insulin sensitivity and may induce adverse metabolic effects like hyperproinsulinemia.

CLA supplements are not a reliable solution for fat loss or metabolic health in humans. While they reduce fat in animals, human studies show minimal to no benefit on body composition and a potential risk of increased insulin resistance, particularly with the trans-10, cis-12 isomer. Focus on diet and exercise instead.

CLA supplementation modulates immune function by altering cytokine levels (increasing anti-inflammatory IL-10, decreasing pro-inflammatory TNF-alpha) and antibody responses, though short-term supplementation in healthy volunteers may not significantly alter overall immune status indices.

CLA may slightly alter specific immune markers like cytokines and antibodies, but it does not appear to provide a significant boost to overall immune function in healthy people. It is not a substitute for a healthy lifestyle in preventing illness.

GLP-1 receptor agonists may increase the risk of adverse heart failure outcomes in patients with heart failure and reduced left ventricular ejection fraction (LVEF), despite showing cardiovascular benefits in other populations.

If you have heart failure with reduced ejection fraction, GLP-1RAs might increase your risk of heart failure complications. Always inform your doctor about your full heart history before starting these medications.

Genetic deficiency of the lipid droplet protein Fsp27 in mice induces white adipose tissue (WAT) to acquire brown adipose tissue (BAT)-like properties, including increased mitochondrial biogenesis, expression of thermogenic genes (Ucp1, PGC1a), and enhanced energy expenditure, resulting in resistance to diet-induced obesity and improved insulin sensitivity.

This research identifies Fsp27 as a key regulator that prevents white fat from burning energy. While this specific genetic modification is not a current human intervention, it highlights the potential of targeting lipid droplet proteins to enhance metabolic rate and insulin sensitivity. Future therapies might aim to modulate Fsp27 activity to promote 'browning' of white fat, potentially aiding in obesity and diabetes management.

HMB improves immune function by increasing lymphocyte blastogenesis and macrophage activity, particularly under stress conditions.

HMB may support immune function, especially during stressful periods, by enhancing immune cell activity.

Activation of AMP-Activated Protein Kinase (AMPK) inhibits white adipose tissue (WAT) development and promotes the differentiation of brown/beige adipose tissue, thereby increasing energy expenditure and reducing obesity.

While you cannot directly 'take' AMPK, the paper identifies it as the central regulator of energy balance. Strategies that activate AMPK (such as exercise, caloric restriction, or specific pharmacological targets mentioned like BMP-8b) can shift the body's fat storage from energy-storing white fat to energy-burning brown/beige fat. This suggests that interventions focusing on metabolic rate and fat quality are more effective than those focusing solely on fat quantity.

Doubling dietary leucine intake via drinking water supplementation improves glucose tolerance, insulin signaling, and reduces hepatic steatosis and adipose inflammation in high-fat diet-induced obese mice without altering total body weight or food intake.

In a mouse model of obesity, doubling dietary leucine (via water supplementation) improved how the body handles glucose and reduced liver fat and inflammation, without causing weight loss. This suggests that ensuring adequate leucine intake might support metabolic health in obese individuals, although human translation requires caution as this was an animal study.